The 70 references in paper A. Shishkin N., M. Lyndina L., А. Шишкин Н., М. Лындина Л. (2009) “ЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ, МЕТАБОЛИЧЕСКИЙ СИНДРОМ И МИКРОАЛЬБУМИНУРИЯ // ENDOTHELIAL DYSFUNCTION, METABOLIC SYNDROME AND MICROALBUMINURIA” / spz:neicon:nefr:y:2009:i:3:p:24-32

1
Строев ЮИ, Цой МВ, Чурилов ЛП, Шишкин АН. Клас­ сические и современные представления о метаболическом синдроме. Часть 1. Критерии, эпидемиология, этиология. Вестник СПбГУ, серия 11; 2007 (1): 13-16
(check this in PDF content)
2
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Healthhand Nutrition Examination Survey. JAMA 2002; 287: 356-359
(check this in PDF content)
3
Lemieux I, Pascot A, Couillard C et.al. Hypertriglyceridemic waist: a marker of the atherogenicmetabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184
(check this in PDF content)
4
Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-34
(check this in PDF content)
5
Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
(check this in PDF content)
6
Бутрова СА. Метаболический синдром и роль абдо­ минального ожирения в его развитии (вопросы патогенеза, проявления, современные подходы к лечению). Ожирение. Метаболический синдром. Сахарный диабет 2 типа. Под ред. ИИ Дедова. М., 2000: 38-43
(check this in PDF content)
7
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. JAMA 2001; 285: 2486-2497
(check this in PDF content)
8
Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for critical appraisal: Joint statement of ADA and EASD. Diabetologia 2005; 48: 1684-1699
(check this in PDF content)
9
International Diabetes Federation. Promoting diabetes care, prevention and cure worldwide. Backgrounder I. The IDP consensus worldwide definition of the metabolic syndrome. P. 1-7. [7 screens, 2 June 2005]
(check this in PDF content)
10
Зайчик АШ, Чурилов ЛП, Строев ЮИ. Понятие о мета­ болическом синдроме. Патофизиология. Т. II. Патохимия. Патофизиология эндокринной системы и метаболизма. 3-е изд. СПб., 2007
(check this in PDF content)
11
Иванова ОВ, Соболева ГН, Карпов ЮА. Эндотели­ альная дисфункция - важный этап развития атеросклеро­ тического поражения сосудов (обзор литературы - 1). Тер арх 1997; (6): 75-78
(check this in PDF content)
12
Adams MR, Robinson J, McCredie R, Seale JP et al. Smooth muscle dysfunction occurs independently of impaired endothelium -dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32(1): 123-127
(check this in PDF content)
13
Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87:840-844
(check this in PDF content)
14
Ройтберг ГЕ. Метаболический синдром. МЕД- пресс - информ, М., 2007
(check this in PDF content)
15
Панина ИЮ, Румянцев АШ, Меншутина МА и др. Осо­ бенности функции эндотелия при хронической болезни по­ чек. Обзор литературы и собственные данные. Нефрология 2007; 11 (4): 28-42
(check this in PDF content)
16
Петрищев НН, Власов ТД. Физиология и патофизи­ ология эндотелия. В: Петрищев Н.Н., ред. Дисфункция эн­ дотелия. Причины, механизмы, фармакологическая коррекция. Изд-во СПбГМУ, СПб., 2003; 4-38
(check this in PDF content)
17
Петрищев НН. Современные аспекты эндотелиоп- ротекции в клинической практике. Ангиопротекция в прак­ тике терапевта: Материалы III Конгресса терапевтов Санкт-Петербурга и Северо-Западного Федерального ок­ руга России. СПб., 2004; 3-6
(check this in PDF content)
18
Britten MB, Zeiher AM, Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 1999; 245(4): 315-321
(check this in PDF content)
19
Шишкин АН, Кирилюк ДВ. Дисфункция эндотелия у пациентов с прогрессирующими заболеваниями почек. Нефрология 2005; 9(2): 16-22
(check this in PDF content)
20
Noguera A, Busquets X, Sauleda J et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic pulmonary disease. Am J Crit Care Med 1998; 158(5): 1664-1668
(check this in PDF content)
21
Помазков ОА. Пептиды в кардиологии. Биохимия. Физиология. Патология. Информация. Анализ. Материк Альфа, М., 2000; 143
(check this in PDF content)
22
Дедов ИИ, Шестакова МВ, Кочемасова ТВ и др. Дис­ функция эндотелия в развитии сосудистых осложнений сахарного диабета. Рос физиол журн им И.М.Сеченова 2001; 87(8): 1073-1084
(check this in PDF content)
23
Shirahase H, Fujiwara M, Usui H, Kurahashi K. A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral artery. Blood Vessels 1987; 24: 117-119
(check this in PDF content)
24
Kato T, Iwama I, Okumura K et al. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990; 15: 475-482
(check this in PDF content)
25
Marie I, Beny JL. Endothelial dysfunction in murine model of systemic sclerosis. J Invest Dermatol 2002; 119 (6): 1379-1385
(check this in PDF content)
26
Feletou M, Busse R, Edwards G et al. Med Sci 2003; 19: 1242-1250
(check this in PDF content)
27
Реутов ВП, Сорокина ЕГ, Косицын НС. Успехи совре­ менной биологии 2005; 25(1): 41-65
(check this in PDF content)
28
Ванин АФ. Биохимия. 1998; 63(7): 867-869
(check this in PDF content)
29
Becker RC. The role of blood viscosity in the development and progression of coronary artery disease. Cleve Clin J Med 1993; 60(5): 353-358
(check this in PDF content)
30
Feletou M, Vanhoutte PM. The alternative: EDHF. J Mol Cell Cardiol 1999 (31): 15-22
(check this in PDF content)
31
Bergman R. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 2000; 43: 946-953
(check this in PDF content)
32
Петрищев НН, ред. Дисфункция эндотелия. Причи­ ны, механизмы, фармакологическая коррекция. СПб., 2003; 4-39
(check this in PDF content)
33
Paloshi A, Fragasso G, Piatti P, et al. Effect of oral L- arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004; 93(7): 933-935
(check this in PDF content)
34
Шестакова МВ. Дисфункция эндотелия - причина или следствие метаболического синдрома? РМЖ 2001; 9(2): 32-35
(check this in PDF content)
35
Lippincott MF, Carlow A, Desai A, Blum A, Rodrigo M, et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. Am Coll Cardiol 2008; 102, (3): 643-647
(check this in PDF content)
36
Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113: 499-506
(check this in PDF content)
37
Suzuki T, Hirata K, Elkind MSV et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the northern Manhattan study (NOMAS). Am Heart J 2008; 156: 405-10
(check this in PDF content)
38
Patel VA., Zhang QJ, Siddle K, Seos MA, Goddard M, Weissberg PL, Benett MR: Defect in insulin-like growth factor- I survival mechanisms in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 2001; 88: 895-902
(check this in PDF content)
39
Reaven GM, Lithell H, Landsberg L. Hypertension and associated m etabolic abnorm alities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381
(check this in PDF content)
40
Spallarossa P, Brunelli C, Minuto F et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 1996; 77: 200-202
(check this in PDF content)
41
Janssen J, Stolk RP, Pols H, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFBP-I levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol [Erratum (1998) 18:1197] 1998; 18: 277-282
(check this in PDF content)
42
Beld AW, Bots ML et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31
(check this in PDF content)
43
Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002; 106: 939-944
(check this in PDF content)
44
Laughlin GA, Barrett-Connor E, Criqui MH, Kritz- Silverstein D: The prospective association of serum insulin­ like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89: 114-120
(check this in PDF content)
45
Johnsen SP, Hundborg HH, Sorensen HT et al. Insulin­ like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005; 90: 5937-5941
(check this in PDF content)
46
Kaplan RC, McGinn AP, Pollak MN et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007; 92: 1319-1325
(check this in PDF content)
47
Perticone F, Sciacqua A, Perticone M et al. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endoc Metab 2008; 92 (7): 1567-1572
(check this in PDF content)
48
Шишкин АН. Дисфункция эндотелия и микроальбу­ минурия. Клиническое значение и терапевтические подхо­ ды. Передовые медицинские технологии практическому здравоохранению. СПб., 2008; 193-199
(check this in PDF content)
49
Karalliedde J, Viberti G. M icroalbum inuria and cardiovascular risk. Am J Hipertens 2004; 17:986-993
(check this in PDF content)
50
Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease m ortality associated with microalbuminuria and gross proteinuria in persons with older- onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100
(check this in PDF content)
51
Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426
(check this in PDF content)
52
Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Am Intern Med 2003; 139:901-906
(check this in PDF content)
53
Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/ creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143:319-326
(check this in PDF content)
54
Ravera M, Ratto E, Vettoretti S et al. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 2002; 15:519-524
(check this in PDF content)
55
Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophisiology, and therapeutic implications. Am J Kidney Dis 1999; 34:973-995
(check this in PDF content)
56
American Diabetes Association: Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31[suppl. I]: S12-S54
(check this in PDF content)
57
Volpe M. Microalbuminuria screening in patients with hypertension: recommendation for clinical practice. Int J Clin Pract 2008; 62(1): 97-108
(check this in PDF content)
58
Jassal SK, Langenberg C, von Muhlen D, Bergstrom J, Barett-Connor E. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men > 40 tears of age (from the Rancho Bernardo Study). Am J Cardiol 2008; 101:1275-1280
(check this in PDF content)
59
Gimeno-Orna JA. Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome. Rev Esp Cardiol 2007; 60(11):1202-1205
(check this in PDF content)
60
Diercks GF, Stroes ES, van Boven AJ, et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-m ediated vasodilation. In apparently healthy subjects. Atherosclerosis 2002; 163(1):121-126
(check this in PDF content)
61
Clausen P, Jensen JS, Jensen G, et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103(14): 1869-1874
(check this in PDF content)
62
Шишкин АН. Современная стратегия терапии эндо­ телиальной дисфункции с позиции доказательной меди­ цины. Новые Санкт-Петербургские Врачебные Ведомости 2008 (3): 16-19
(check this in PDF content)
63
Anderson TJ, Meredith IT, Yeung AC et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium- dependent coronary vasomotion. N Engl J Med 1995; 332(8): 488-493
(check this in PDF content)
64
Roque M, Heras M, Roig E, et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in post-menopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998; 31(1): 139-143
(check this in PDF content)
65
Kaski JC. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 2002; 53(3): 620-626
(check this in PDF content)
66
Rosano GM, Peters NS, Lefroy D, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28(6):1500-1505
(check this in PDF content)
67
Knoops KT, de Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292(12): 1433-1439
(check this in PDF content)
68
Gokce N, Vita JA, McDonnell M et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005; 95(2): 266-268
(check this in PDF content)
69
Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DC. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 1999; 130(7): 578-581
(check this in PDF content)
70
Мухин НА, Арутюнов ГП, Фомин ВВ. Альбуминурия - маркер поражения почек и риска сердечно-сосудистых осложнений. Клиническая нефрология 2009 (1): 5-10 Поступила в редакцию 30.06.2009 г. Принята в печать 13.07.2009 г.
(check this in PDF content)